Volume 67, Issue 2, Pages (February 2005)

Slides:



Advertisements
Similar presentations
An unusual case of pulmonary-renal syndrome associated with defects in type IV collagen composition and anti-glomerular basement membrane autoantibodies 
Advertisements

Volume 72, Issue 7, Pages (October 2007)
Volume 78, Issue 12, Pages (December 2010)
Volume 64, Issue 6, Pages (December 2003)
Volume 65, Issue 4, Pages (April 2004)
Volume 79, Issue 9, Pages (May 2011)
Volume 72, Issue 10, Pages (November 2007)
Anti-DNA autoantibodies initiate experimental lupus nephritis by binding directly to the glomerular basement membrane in mice  Meera R. Krishnan, Congmiao.
Volume 81, Issue 2, Pages (January 2012)
Volume 66, Issue 3, Pages (September 2004)
Retransplantation in Alport post-transplant anti-GBM disease
Volume 78, Issue 12, Pages (December 2010)
Volume 72, Issue 6, Pages (September 2007)
Volume 61, Issue 5, Pages (May 2002)
Volume 82, Issue 1, Pages (July 2012)
Volume 64, Issue 1, Pages (July 2003)
Volume 90, Issue 1, Pages (July 2016)
Volume 37, Issue 6, Pages (December 2012)
Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals  Zhao Cui, Ming-hui Zhao,
Volume 82, Issue 1, Pages (July 2012)
Volume 66, Issue 6, Pages (December 2004)
Volume 72, Issue 7, Pages (October 2007)
Volume 63, Issue 1, Pages (January 2003)
Volume 66, Issue 5, Pages (November 2004)
Lanlin Chen, Thomas Hellmark, Jörgen Wieslander, Warren Kline Bolton 
Volume 77, Issue 5, Pages (March 2010)
Volume 68, Issue 1, Pages (July 2005)
Volume 56, Issue 3, Pages (September 1999)
Volume 64, Issue 4, Pages (October 2003)
B-1a and B-1b Cells Exhibit Distinct Developmental Requirements and Have Unique Functional Roles in Innate and Adaptive Immunity to S. pneumoniae  Karen.
Volume 81, Issue 9, Pages (May 2012)
Volume 56, Issue 2, Pages (August 1999)
Volume 80, Issue 12, Pages (December 2011)
Volume 67, Issue 5, Pages (May 2005)
Volume 68, Issue 3, Pages (September 2005)
Volume 58, Issue 1, Pages (July 2000)
Volume 54, Issue 5, Pages (November 1998)
Volume 66, Issue 3, Pages (September 2004)
Volume 86, Issue 5, Pages (November 2014)
Volume 70, Issue 2, Pages (July 2006)
Volume 65, Issue 1, Pages (January 2004)
Regulatory interactions of αβ and γλ T cells in glomerulonephritis
Stephen R. Holdsworth, A. Richard Kitching, Peter G. Tipping 
Glomerular injury is exacerbated in diabetic integrin α1-null mice
Local macrophage proliferation in human glomerulonephritis
Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals  Zhao Cui, Ming-hui Zhao,
Volume 68, Issue 2, Pages (August 2005)
The C5a receptor has a key role in immune complex glomerulonephritis in complement factor H–deficient mice  Jessy J. Alexander, Lee Chaves, Anthony Chang,
Volume 71, Issue 7, Pages (April 2007)
Volume 66, Issue 4, Pages (October 2004)
Volume 81, Issue 2, Pages (January 2012)
Volume 66, Issue 4, Pages (October 2004)
Volume 57, Issue 1, Pages (January 2000)
Erratum: SLE: translating lessons from model systems to human disease
A Critical Role for Complement in Maintenance of Self-Tolerance
Volume 64, Issue 3, Pages (September 2003)
Volume 72, Issue 7, Pages (October 2007)
Volume 57, Issue 2, Pages (October 2000)
Volume 67, Issue 3, Pages (March 2005)
Joshua D. Ooi, A. Richard Kitching  Kidney International 
Antiglomerular basement membrane disease with normal renal function
Volume 66, Issue 3, Pages (September 2004)
Volume 54, Pages S189-S191 (September 1998)
Membranous and crescentic glomerulonephritis in a patient with anti-nuclear and anti- neutrophil cytoplasmic antibodies  A. Chang, O. Aneziokoro, S.M.
Volume 62, Issue 1, Pages (July 2002)
Volume 63, Issue 1, Pages (January 2003)
Volume 67, Issue 6, Pages (June 2005)
Jens Gaedeke, Nancy A. Noble, Wayne A. Border  Kidney International 
Volume 58, Issue 5, Pages (November 2000)
Volume 78, Issue 3, Pages (August 2010)
Presentation transcript:

Volume 67, Issue 2, Pages 566-575 (February 2005) Experimental autoimmune Goodpasture's disease: A pathogenetic role for both effector cells and antibody in injury  Elizabeth G. Dean, Gabrielle R.A. Wilson, Ming Li, Kristy L. Edgtton, K.I.M.M. O'Sullivan, Billy G. Hudson, Stephen R. Holdsworth, A. Richard Kitching  Kidney International  Volume 67, Issue 2, Pages 566-575 (February 2005) DOI: 10.1111/j.1523-1755.2005.67113.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 μT+/+ and μT+/- mice have intact B cells (A and B) by flow cytometry and humoral responses. They make antibodies to the disease-initiating antigen (D) by enzyme-linked immunosorbent assay (ELISA) detecting serum immunoglobulin against α3-α5(IV)NC1 dimers, that bind to the glomerular basement membrane (GBM) in a linear fashion (E and F). μT-/- mice have no B cells (C), no serum antibody against α3-α5(IV)NC1 (D), and do not exhibit antibodies that bind to the GBM (G). Data are expressed as the mean ± SEM. GN is glomerulonephritis; OD is optical density. Kidney International 2005 67, 566-575DOI: (10.1111/j.1523-1755.2005.67113.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Both B-cell–intact and B-cell–deficient mice develop renal injury in experimental autoimmune glomerulonephritis (EAG). Both antibody-deficient and antibody-intact mice developed similar numbers of abnormal glomeruli (A), glomerular hypercellularity (B), glomerular CD4+ cells (C), and Mac-1+ cells (D). The dotted lines represent mean values for mice immunized with adjuvant alone that did not develop glomerulonephritis. Data are expressed as the mean ± SEM. Kidney International 2005 67, 566-575DOI: (10.1111/j.1523-1755.2005.67113.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Histological injury in mice with experimental autoimmune glomerulonephritis (EAG). C57BL/6 mice that received Bordetella pertussis antigen and Freund's complete adjuvant (FCA) alone, without α3-α5(IV)NC1 heterodimers did not develop histologic injury (A, D, and G), in contrast to α3-α5(IV)NC1 heterodimer immunized mice. Both B-cell–intact mice (B, E, and H) and B-cell–deficient mice (C, F, and I) developed EAG with proliferative glomerulonephritis (B, C, H, and I) and an occasional glomerular crescent (E and F). In control injected mice, the larger juxtamedullary glomeruli did not exhibit proliferation or matrix accumulation (G), unlike α3-α5(IV)NC1 heterodimer immunized B-cell–intact (H) or B-cell–deficient mice (I) mice [periodic acid-Schiff (PAS) stain original magnification ×200][(G to H) shown at higher final magnification]. Kidney International 2005 67, 566-575DOI: (10.1111/j.1523-1755.2005.67113.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 Proteinuria in B-cell–intact and B-cell–deficient mice with experimental autoimmune glomerulonephritis (EAG). Proteinuria was similar in both B-cell–intact and B-cell–deficient mice. *P < 0.05 vs. predisease induction (t test). Data are expressed as the mean ± SEM. Kidney International 2005 67, 566-575DOI: (10.1111/j.1523-1755.2005.67113.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 5 Indirect and direct immunofluorescence findings in passive transfer studies. Serum from B-cell–intact mice with glomerulonephritis (A and B) or Col4a3-/- mice immunized against renal basement membranes (C and D), but not B-cell–deficient mice with glomerulonephritis (E and F) or unimmunized B-cell–intact mice without glomerulonephritis (G and H), induces linear staining on the glomerular basement membrane (GBM) of RAG-1-/- recipients (A, C, E, and G) indirect immunofluorescence using unmodified μT-/- mouse kidney sections; (B, D, F, and H) direct immunofluorescence in RAG-1-/- recipients. Kidney International 2005 67, 566-575DOI: (10.1111/j.1523-1755.2005.67113.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 6 Proteinuria and glomerular findings in RAG-1-/- mice 48 hours after passive transfer of anti-glomerular basement membrane (GBM) antibodies.RAG-1-/- mice receiving sera from B-cell–intact mice with glomerulonephritis (GN) (+/+GN →RAG-1-/-) or from Col4a3-/- mice immunized with a renal basement membrane preparation (Col4a3-/-→RAG-1-/-) developed proteinuria (A). Negative controls included sera from μT-/- mice with glomerulonephritis (-/-GN →RAG-1-/-) and sera from unimmunized antibody-intact genetically normal mice (+/+no GN →RAG-1-/-). Major histologic abnormalities were not present in mice (B and C). *P < 0.05 compared with both negative control groups [analysis of variance (ANOVA)]. Data are expressed as the mean ± SEM. Kidney International 2005 67, 566-575DOI: (10.1111/j.1523-1755.2005.67113.x) Copyright © 2005 International Society of Nephrology Terms and Conditions